Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population
- PMID: 25748064
- DOI: 10.1016/j.jaci.2015.01.020
Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population
Abstract
Background: Past studies of blood T-cell phenotyping in patients with atopic dermatitis (AD) have provided controversial results and were mostly performed before the identification of TH9, TH17, and TH22 T-cell populations in human subjects.
Objective: We sought to quantify TH1, TH2, TH9, TH17, and TH22 T-cell populations and corresponding CD8(+) T-cell subsets in both cutaneous lymphocyte antigen (CLA)-positive and CLA(-) T-cell subsets in patients with AD and control subjects.
Methods: We studied 42 adults with severe AD (mean SCORAD score, 65) and 25 healthy subjects using an 11-color flow cytometric antibody panel. Frequencies of IFN-γ-, IL-22-, IL-13-, IL-17-, and IL-9-producing CD4(+) and CD8(+) T cells were compared in CLA(-) and CLA(+) populations.
Results: We measured increased TH2/TC2/IL-13(+) and TH22/TC22/IL-22(+) populations (P < .1) in patients with severe AD versus control subjects, with significant differences in CLA(+) T-cell numbers (P < .01). A significantly lower frequency of CLA(+) IFN-γ-producing cells was observed in patients with AD, with no significant differences in CLA(-) T-cell numbers. The CLA(+) TH1/TH2 and TC1/TC2 ratio was highly imbalanced in patients with AD (10 vs 3 [P = .005] and 19 vs 7 [P < .001], respectively). Positive correlations were found between frequencies of IL-13- and IL-22-producing CD4(+) and CD8(+) T cells (r = 0.5 and 0.8, respectively; P < .0001), and frequencies of IL-13-producing CLA(+) cells were also correlated with IgE levels and SCORAD scores. Patients with AD with skin infections had higher CD4(+) IL-22(+) and IL-17(+) cell frequencies, which were highly significant among CLA(-) cells (IL-22: 3.7 vs 1.7 [P < .001] and IL-17: 1.7 vs 0.6 [P < .001]), with less significant effects among CLA(+) T cells (IL-22: 11 vs 7.5, P = .04).
Conclusions: Severe AD is accompanied by expansion of skin-homing TH2/TC2 and TH22/TC22 subsets with lower TH1/TC1 frequencies. These data create a critical basis for studying alterations in immune activation in adults and pediatric patients with AD.
Keywords: Atopic dermatitis; IFN-γ; IL-13; IL-22; T cell; cutaneous lymphocyte antigen; skin infections.
Copyright © 2015 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Comment in
-
Reply: To PMID 25748064.J Allergy Clin Immunol. 2015 Dec;136(6):1707-1708. doi: 10.1016/j.jaci.2015.08.030. Epub 2015 Oct 10. J Allergy Clin Immunol. 2015. PMID: 26456036 No abstract available.
-
Leprosy is teaching us the immunopathogenesis of inflammatory skin disease.J Allergy Clin Immunol. 2015 Dec;136(6):1707. doi: 10.1016/j.jaci.2015.08.029. Epub 2015 Oct 10. J Allergy Clin Immunol. 2015. PMID: 26456037 No abstract available.
Similar articles
-
Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(+) TH2/TH1 cell imbalance, whereas adults acquire CLA(+) TH22/TC22 cell subsets.J Allergy Clin Immunol. 2015 Oct;136(4):941-951.e3. doi: 10.1016/j.jaci.2015.05.049. Epub 2015 Aug 1. J Allergy Clin Immunol. 2015. PMID: 26242300 Free PMC article.
-
Alopecia areata is characterized by expansion of circulating Th2/Tc2/Th22, within the skin-homing and systemic T-cell populations.Allergy. 2018 Mar;73(3):713-723. doi: 10.1111/all.13346. Epub 2017 Dec 22. Allergy. 2018. PMID: 29083474
-
Increased circulating skin-homing cutaneous lymphocyte-associated antigen (CLA)+ type 2 cytokine-producing cells, and decreased CLA+ type 1 cytokine-producing cells in atopic dermatitis.Br J Dermatol. 2000 Aug;143(2):373-8. doi: 10.1046/j.1365-2133.2000.03665.x. Br J Dermatol. 2000. PMID: 10951148
-
Circulating CLA+ T cells in atopic dermatitis and their possible role as peripheral biomarkers.Allergy. 2017 Mar;72(3):366-372. doi: 10.1111/all.13080. Epub 2016 Dec 15. Allergy. 2017. PMID: 27861978 Review.
-
Cytokine network and dysregulated apoptosis in atopic dermatitis.Acta Odontol Scand. 2001 Jun;59(3):178-82. doi: 10.1080/000163501750266783. Acta Odontol Scand. 2001. PMID: 11501888 Review.
Cited by
-
Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches.Exp Dermatol. 2019 Jul;28(7):756-768. doi: 10.1111/exd.13911. Epub 2019 Apr 15. Exp Dermatol. 2019. PMID: 30825336 Free PMC article. Review.
-
Type 2 immunity-driven diseases: Towards a multidisciplinary approach.Clin Exp Allergy. 2021 Dec;51(12):1538-1552. doi: 10.1111/cea.14029. Epub 2021 Oct 15. Clin Exp Allergy. 2021. PMID: 34617355 Free PMC article. Review.
-
Childhood atopic dermatitis as a precursor for developing attention deficit/hyperactivity disorder.Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420962902. doi: 10.1177/2058738420962902. Int J Immunopathol Pharmacol. 2020. PMID: 33045857 Free PMC article. Review.
-
sLeX Expression Delineates Distinct Functional Subsets of Human Blood Central and Effector Memory T Cells.J Immunol. 2020 Oct 1;205(7):1920-1932. doi: 10.4049/jimmunol.1900679. Epub 2020 Aug 31. J Immunol. 2020. PMID: 32868410 Free PMC article.
-
Clinical implications of new mechanistic insights into atopic dermatitis.Curr Opin Pediatr. 2016 Aug;28(4):456-62. doi: 10.1097/MOP.0000000000000374. Curr Opin Pediatr. 2016. PMID: 27191525 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous